Jiskra J, Haluzík M, Svobodová J, Haluzíková D, Nedvídková J, Parízková J, Kotrlíková E
III. interní klinika 1. LF UK a VFN, Praha.
Cas Lek Cesk. 2000 Oct 25;139(21):660-3.
Leptin action in peripheral tissues is enabled by an interaction with specific transmembrane receptors. Several of leptin receptor isoforms were identified, including soluble leptin receptor isoform structurally identical to extracellular domain of the the long leptin receptor isoform. The soluble receptor isoform is released to the circulation and acts probably as leptin-binding factor. The aim of our study was to measure serum concentrations of the soluble leptin receptor in patients with anorexia nervosa and in the control group of healthy women. Relationships of soluble leptin receptor levels to body mass index (BMI), body fat content, serum leptin, TNF-alpha and insulin levels were also studied.
16 patients with anorexia nervosa and 16 age-matched lean healthy women were included into the study. All of the subjects were measured and weighed, the body fat content was estimated from the skinfold thickness measurement. The blood for the determination of leptin, soluble leptin receptor and other hormonal parameters was obtained from all subjects after the overnight fasting. BMI, body fat content, serum leptin and insulin levels in patients with anorexia nervosa were significantly lower than in the control group (BMI: 14.98 +/- 2.32 vs. 22.21 +/- 2.48, p < 0.01, % fat content: 16.43 +/- 4.56 vs. 27.19 +/- 4.59, p < 0.01, leptin: 1.37 +/- 1.85 ng.ml-1 vs. 7.19 +/- 3.49 ng.ml-1, p < 0.01, insulin: 12.97 +/- 2.89 mU.l-1 vs. 17.09 +/- 5.57 mU.l-1, p < 0.05). Serum soluble leptin receptor levels in patients with anorexia nervosa were significantly higher compared the to control group (24.67 +/- 8.3 U.ml-1 vs. 15.71 +/- 2.79 U.ml-1, p < 0.01). No significant differences in serum TNF-alpha levels between the groups studied were found. Serum leptin levels in both groups correlated positively with BMI and body fat content. Serum soluble leptin receptor levels in both groups correlated negatively with BMI only. No statistically significant relationships between serum soluble leptin receptor levels and the rest of parameters studied were found in any of the groups studied.
Serum soluble leptin receptors levels in patients with anorexia nervosa were significantly higher in comparison with the healthy subjects. Except of the negative correlation between serum soluble leptin receptor levels and BMI no statistically significant relationships between serum soluble leptin receptor and the rest of parameters studied were found.
瘦素在周围组织中的作用是通过与特定跨膜受体相互作用来实现的。已鉴定出几种瘦素受体亚型,包括结构上与长型瘦素受体亚型的细胞外结构域相同的可溶性瘦素受体亚型。可溶性受体亚型释放到循环中,可能作为瘦素结合因子发挥作用。我们研究的目的是测量神经性厌食症患者和健康女性对照组中可溶性瘦素受体的血清浓度。还研究了可溶性瘦素受体水平与体重指数(BMI)、体脂含量、血清瘦素、肿瘤坏死因子-α(TNF-α)和胰岛素水平之间的关系。
16例神经性厌食症患者和16例年龄匹配的健康瘦女性纳入研究。对所有受试者进行测量和称重,通过皮褶厚度测量估算体脂含量。所有受试者在过夜禁食后采集血液,用于测定瘦素、可溶性瘦素受体和其他激素参数。神经性厌食症患者的BMI、体脂含量、血清瘦素和胰岛素水平显著低于对照组(BMI:14.98±2.32 vs. 22.21±2.48,p<0.01;体脂百分比:16.43±4.56 vs. 27.19±4.59,p<0.01;瘦素:I.37±1.85 ng.ml-1 vs. 7.19±3.49 ng.ml-1,p<0.01;胰岛素:12.97±2.89 mU.l-1 vs. 17.09±5.57 mU.l-1,p<0.05)。神经性厌食症患者的血清可溶性瘦素受体水平显著高于对照组(24.67±8.3 U.ml-1 vs. 15.71±2.79 U.ml-1,p<0.01)。研究组之间血清TNF-α水平未发现显著差异。两组的血清瘦素水平均与BMI和体脂含量呈正相关。两组的血清可溶性瘦素受体水平均仅与BMI呈负相关。在任何研究组中,血清可溶性瘦素受体水平与其他研究参数之间均未发现统计学上的显著关系。
与健康受试者相比,神经性厌食症患者的血清可溶性瘦素受体水平显著更高。除血清可溶性瘦素受体水平与BMI呈负相关外,血清可溶性瘦素受体与其他研究参数之间未发现统计学上的显著关系。